Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic

Robert M Hughes1,2,3, Brian W Simons1, Hamda Khan1,2,3

  • 1The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland.

Cancer Research
|May 25, 2019
PubMed

Insights

Asporin (ASPN), a factor from mesenchymal stromal cells (MSCs), drives tumor metastasis by altering the tumor microenvironment. Blocking ASPN reduces metastasis and impacts tumor-associated cells.

Area of Science:

  • Oncology
  • Cell Biology
  • Tumor Microenvironment Research

Background:

  • Tumor metastasis involves complex interactions within the tumor microenvironment, not just cancer cells.
  • Mesenchymal stromal cells (MSCs) are key components of this microenvironment, influencing tumor progression.

Purpose of the Study:

  • To identify novel factors secreted by MSCs that regulate metastatic development.
  • To elucidate the role of asporin (ASPN) in the tumor microenvironment and its impact on metastasis.

Main Methods:

  • Investigated ASPN expression in MSCs and its correlation with differentiation.
  • Utilized ASPN-null mice to assess the in vivo impact of ASPN on prostate tumor growth and metastasis.
  • Analyzed tumor microenvironment composition, including MSCs, cancer stem cells, vasculature, and immune cells.

Main Results:

  • ASPN is highly expressed in MSCs and regulates their self-renewal and differentiation.
  • Secreted ASPN binds BMP-4, inhibiting MSC differentiation.
  • ASPN expression is conserved in cancer-associated fibroblasts (CAFs).
  • ASPN-null mice exhibited reduced tumor-associated MSCs, fewer cancer stem cells, decreased vasculature, and increased CD8+ T cells.
  • ASPN deficiency significantly reduced lung metastases in prostate tumor models.

Conclusions:

  • Asporin (ASPN) is a critical secreted factor from mesenchymal stromal cells (MSCs) that promotes tumor metastatic progression.
  • ASPN extensively modulates the tumor microenvironment, affecting multiple cell types and promoting metastasis.
  • Targeting ASPN may represent a novel therapeutic strategy to inhibit cancer metastasis.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Energy to Drive Translocation01:37

Energy to Drive Translocation

Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
2.7K
Alterations in Respiration II01:30

Alterations in Respiration II

There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
1.7K
Restriction Enzymes01:11

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
35.8K